PGEN Cash-Secured Put Strategy
PGEN (Precigen, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC.
PGEN (Precigen, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.63B, a trailing P/E of 66.64, a beta of 0.98 versus the broader market, a 52-week range of 3.04-8.98, average daily share volume of 5.6M, a public-listing history dating back to 2013, approximately 160 full-time employees. These structural characteristics shape how PGEN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.98 places PGEN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 66.64 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a cash-secured put on PGEN?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
PGEN snapshot
As of November 13, 2026, spot at $4.54, ATM IV 90.50%, IV rank 39.58%, expected move 25.95%. The cash-secured put on PGEN below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this cash-secured put structure on PGEN specifically: PGEN IV at 90.50% is mid-range versus its 1-year history, so the credit collected on a PGEN cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 25.95% (roughly $1.18 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PGEN expiries trade a higher absolute premium for lower per-day decay. Position sizing on PGEN should anchor to the underlying notional of $4.54 per share and to the trader's directional view on PGEN stock.
PGEN cash-secured put setup
The PGEN cash-secured put below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PGEN at $4.54 on that close, the first option leg uses a $4.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PGEN chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PGEN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $4.50 | $0.58 |
PGEN cash-secured put risk and reward
- Net Premium / Debit
- +$57.50
- Max Profit (per contract)
- $57.50
- Max Loss (per contract)
- -$391.50
- Breakeven(s)
- $3.93
- Risk / Reward Ratio
- 0.147
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
PGEN cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on PGEN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.8% | -$391.50 |
| $1.01 | -77.7% | -$291.23 |
| $2.02 | -55.6% | -$190.96 |
| $3.02 | -33.5% | -$90.69 |
| $4.02 | -11.4% | +$9.59 |
| $5.02 | +10.7% | +$57.50 |
| $6.03 | +32.7% | +$57.50 |
| $7.03 | +54.8% | +$57.50 |
| $8.03 | +76.9% | +$57.50 |
| $9.03 | +99.0% | +$57.50 |
When traders use cash-secured put on PGEN
Cash-secured puts on PGEN earn premium while a trader waits to acquire PGEN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning PGEN.
PGEN thesis for this cash-secured put
The market-implied 1-standard-deviation range for PGEN extends from approximately $3.36 on the downside to $5.72 on the upside. A PGEN cash-secured put lets a trader earn premium while waiting to acquire PGEN at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current PGEN IV rank near 39.58% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on PGEN should anchor more to the directional view and the expected-move geometry. As a Healthcare name, PGEN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PGEN-specific events.
PGEN cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PGEN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PGEN alongside the broader basket even when PGEN-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on PGEN carry tail risk when realized volatility exceeds the implied move; review historical PGEN earnings reactions and macro stress periods before sizing. Always rebuild the position from current PGEN chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on PGEN?
- A cash-secured put on PGEN is the cash-secured put strategy applied to PGEN (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With PGEN stock at $4.54 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed PGEN chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are PGEN cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the PGEN cash-secured put priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 90.50%), the computed maximum profit is $57.50 per contract and the computed maximum loss is -$391.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PGEN cash-secured put?
- The breakeven for the PGEN cash-secured put priced on this page is roughly $3.93 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The PGEN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 25.95%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on PGEN?
- Cash-secured puts on PGEN earn premium while a trader waits to acquire PGEN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning PGEN.
- How does current PGEN implied volatility affect this cash-secured put?
- PGEN ATM IV is at 90.50% with IV rank near 39.58%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.